Fibulin 1 Protein (FBLN1) (Transcript Variant D) (Myc-DYKDDDDK Tag)
-
- Target See all Fibulin 1 (FBLN1) Proteins
- Fibulin 1 (FBLN1)
- Protein Type
- Recombinant
- Protein Characteristics
- Transcript Variant D
-
Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This Fibulin 1 protein is labelled with Myc-DYKDDDDK Tag.
- Application
- Antibody Production (AbP), Standard (STD)
- Characteristics
-
- Recombinant human Fibulin-1 (transcript variant D) protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Purity
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
- Top Product
- Discover our top product FBLN1 Protein
-
-
- Application Notes
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Comment
-
The tag is located at the C-terminal.
- Restrictions
- For Research Use only
-
- Concentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Storage
- -80 °C
- Storage Comment
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- Fibulin 1 (FBLN1)
- Alternative Name
- Fibulin-1 (FBLN1 Products)
- Synonyms
- fbln1 Protein, FBLN Protein, FIBL1 Protein, fbln1c Protein, fbln1d Protein, wu:fc52c06 Protein, MGC115035 Protein, fibulin 1 Protein, fibulin 1 L homeolog Protein, FBLN1 Protein, fbln1 Protein, Fbln1 Protein, fbln1.L Protein, CpipJ_CPIJ017419 Protein
- Background
- Fibulin 1 is a secreted glycoprotein that becomes incorporated into a fibrillar extracellular matrix. Calcium-binding is apparently required to mediate its binding to laminin and nidogen. It mediates platelet adhesion via binding fibrinogen. Four splice variants which differ in the 3' end have been identified. Each variant encodes a different isoform, but no functional distinctions have been identified among the four variants.
- Molecular Weight
- 74.6 kDa
- NCBI Accession
- NP_006477
-